We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Non-Invasive Medical Imaging Test Predicts Dementia Nine Years before Diagnosis

By MedImaging International staff writers
Posted on 12 Jun 2024
Print article
Image: The first-of-its-kind test predicts dementia with over 80% accuracy and up to nine years before diagnosis (Photo courtesy of Queen Mary University of London)
Image: The first-of-its-kind test predicts dementia with over 80% accuracy and up to nine years before diagnosis (Photo courtesy of Queen Mary University of London)

Predicting future cases of dementia is crucial for developing interventions aimed at preventing the irreversible loss of brain cells responsible for dementia symptoms. While advancements have been made in identifying brain proteins linked to Alzheimer’s disease, many individuals carry these proteins for years without exhibiting dementia symptoms. Currently, dementia is commonly diagnosed through memory tests or by measuring brain shrinkage. Now, a newly developed method offers over 80% accuracy in predicting dementia up to nine years before an official diagnosis, providing a more precise approach to early identification.

Researchers at Queen Mary University of London (London, UK) developed this predictive test by analyzing functional MRI (fMRI) scans to assess changes in the brain’s ‘default mode network’ (DMN), which is essential for cognitive functions and is the first neural network impacted by Alzheimer’s disease. Utilizing fMRI scans from more than 1,100 volunteers from the UK Biobank—a comprehensive biomedical database containing health and genetic information from half a million UK participants—the team evaluated the effective connectivity among ten brain regions that make up the DMN. Each participant was assigned a probability of developing dementia based on how closely their connectivity patterns matched those typically seen in dementia versus control-like patterns.

The predictions were then matched against the medical records of the participants from the UK Biobank. Results demonstrated that the model could accurately forecast the onset of dementia up to nine years before it was officially diagnosed, with an accuracy rate exceeding 80%. For those who eventually developed dementia, the model was also able to predict, within a two-year margin of error, the timeline until diagnosis. Further investigations by the researchers explored whether alterations to the DMN could be attributed to known dementia risk factors. Their findings indicated that genetic predispositions to Alzheimer’s disease strongly correlated with connectivity changes in the DMN, reinforcing the notion that these alterations are specific to Alzheimer’s. Additionally, they noted that social isolation could increase dementia risk due to its impact on DMN connectivity.

“Using these analysis techniques with large datasets we can identify those at high dementia risk, and also learn which environmental risk factors pushed these people into a high-risk zone. Enormous potential exists to apply these methods to different brain networks and populations, to help us better understand the interplays between environment, neurobiology and illness, both in dementia and possibly other neurodegenerative diseases,” said Samuel Ereira, lead author and Academic Foundation Program Doctor at the Centre for Preventive Neurology, Wolfson Institute of Population Health. “fMRI is a non-invasive medical imaging tool, and it takes about 6 minutes to collect the necessary data on an MRI scanner, so it could be integrated into existing diagnostic pathways, particularly where MRI is already used.”

Related Links:
Queen Mary University of London

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Portable X-ray Unit
AJEX130HN
New
CT Detector
PURE INSIGHT
LED-Based X-Ray Viewer
Dixion X-View

Print article
Radcal

Channels

Ultrasound

view channel
Image: Disease captured by the hand-held 3D photoacoustic scanner (Photo courtesy of Dr. Nam Huynh)

Medical Imaging Breakthrough to Revolutionize Cancer and Arthritis Diagnosis

Photoacoustic tomography (PAT) imaging uses laser-generated ultrasound waves to detect subtle changes in small veins and arteries, typically less than a millimeter in size and up to 15mm deep in human tissues.... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.